SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $77,000 | -29.4% | 14,200 | -2.7% | 0.00% | -33.3% |
| Q1 2021 | $109,000 | -29.2% | 14,600 | +2.8% | 0.00% | -25.0% |
| Q4 2020 | $154,000 | +20.3% | 14,200 | -2.1% | 0.00% | -33.3% |
| Q3 2020 | $128,000 | -15.2% | 14,500 | +2.1% | 0.01% | -25.0% |
| Q2 2020 | $151,000 | +1272.7% | 14,200 | +1094.3% | 0.01% | +700.0% |
| Q2 2019 | $11,000 | +37.5% | 1,189 | +58.5% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | +60.0% | 750 | +53.1% | 0.00% | – |
| Q4 2017 | $5,000 | -54.5% | 490 | -34.7% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | -42.1% | 750 | -37.8% | 0.00% | -50.0% |
| Q2 2017 | $19,000 | – | 1,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |